Nova Technologies Inc/DE – ‘NT 10-K’ for 12/31/97

As of:  Thursday, 3/26/98   ·   For:  12/31/97   ·   Accession #:  950117-98-628   ·   File #:  33-42880

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Notice of a Late Filing of a Form 10-K   —   Form 12b-25
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: NT 10-K     Vivax Medical Corporation                              4     12K 

NT 10-K
1st Page of 4
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
                                                Commission File Number: 33-42880

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 12B-25 

NOTIFICATION OF LATE FILING 

(Check One):

[X] Form 10-K   [ ] Form 11-K [ ] Form 20-F                   
[ ] Form 10-Q                 [ ] Form N-SAR                  

For Period Ended: December 31, 1997                           

[ ]Transition Report on Form 10-K                             
[ ]Transition Report on Form 20-F                             
[ ]Transition Report on Form 11-K                             
[ ]Transition Report on Form 10-Q                             
[ ]Transition Report on Form N-SAR                            

For the Transition Period Ended:                              
                                         ---------------------------------------
--------------------------------------------------------------------------------

        Read Attached Instruction Sheet Before Preparing Form. Please Print or
Type.                                                         

      Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.                

--------------------------------------------------------------------------------

       If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:                         

         -----------------------------------------------------------------------
         -----------------------------------------------------------------------

--------------------------------------------------------------------------------

PART I -- REGISTRANT INFORMATION                                                

--------------------------------------------------------------------------------

Full Name of Registrant: Vivax Medical Corporation            

Former Name if Applicable:                                    

545 Middle Street                                             
         -----------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)     

Bristol, CT 06010                                             
         -----------------------------------------------------------------------
City, State and Zip Code                                      

--------------------------------------------------------------------------------

PART II -- RULES 12B-25 (B) AND (C)                                             

--------------------------------------------------------------------------------

If the subject report could not be filed without unreasonable effort or expense 
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)                                        

NT 10-K
2nd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 2nd
[X]      (a)      The reasons described in reasonable detail in Part III of this
               form could not be eliminated without unreasonable effort or
expense;                                    

[X]      (b)      The subject annual report, semi-annual report, transition     
                  report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion
            thereof will be filed on or before the 15th calendar day
               following the prescribed due date; or the subject quarterly
                report or transition report on Form 10-Q, or portion thereof
               will be filed on or before the fifth calendar day following
the prescribed due date; and                

[ ]      (c)      The accountant's statement or other exhibit required by Rule  
12b-25(c) has been attached if applicable.  

--------------------------------------------------------------------------------

PART III -- NARRATIVE                                                           

--------------------------------------------------------------------------------

State below in reasonable  detail the reasons why Form 10-K, 20-F, 10-Q, N-SAR  
or the transition report or portion thereof could not be filed within the       
prescribed period.                                                              
                                                 (Attach Extra Sheets if Needed)

     Registrant was unable to file Form 10-K due to an inability to timely
obtain all information to make full and complete disclosure of its financial    
results.                                                                        

--------------------------------------------------------------------------------

PART IV -- OTHER INFORMATION                                                    

--------------------------------------------------------------------------------

    (1) Name and telephone number of person to contact in regard to this
notification:                                                                   

Harold J. Lash                        (203) 862-8572          
         -----------------------------------------------------------------------
     (Name)                                (Area Code)(Telephone Number)

      (2) Have all other periodic reports required under section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the Investment Company  
Act of 1940 during the preceding 12 months or for such shorter period that the  
registrant was required to file such report(s) been filed? If the answer is no, 
identify report(s).                                                             

                                                                    [X]Yes [ ]No

(3) Is it anticipated that any significant change in results of 
operations from the corresponding period for the last fiscal year will be       
reflected by the earnings statements to be included in the subject report or    
portion thereof?                                                                

                                                                    [X]Yes [ ]No

        If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable     
estimate of the results cannot be made.                                         

-2- 

NT 10-K
3rd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 3rd
Vivax Medical Corportion
--------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned      
hereunto duly authorized.                                                       

Date March 26, 1998               By  /s/ Stephen M. Fisher                     
-------------                   -----------------------------         
           Stephen M. Fisher
   President

-3- 

NT 10-K
Last Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 4th
ATTACHMENT TO FORM 12B-25 

of    

VIVAX MEDICAL CORPORATION 
PART IV (3)   

It is anticipated that the Registrant's earnings statement to be included with  
its Form 10-KSB will reflect a net loss for the year of approximately           
$3,100,000, compared to a net loss for its last fiscal year of $2,053,757.      
The change in results of operations is due primarily to increases in general    
and administrative, interest and manufacturing overhead expenses which were     
partially offset by increased sales resulting from the acquisitions of Concept  
Medical Systems, Inc. on September 30, 1997 and Comed Systems, Inc. on June 14, 
1996 (both currently divisions of Vivax Medical Systems, Inc., a subsidiary of  
the Registrant).                                                                

-4- 

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘NT 10-K’ Filing		Date		First		Last			Other Filings
Filed on:		3/26/98		3
For Period End:		12/31/97		1
		9/30/97		4					10QSB
		6/14/96		4
									List all Filings